Wow! What a tailwind!!
Oventus CEO, Dr Chris Hart commented, “As literature continues to highlight that CPAP may contribute to COVID-19 spread, effective alternative OSA treatments are being sought. Oventus technology is increasingly in the spotlight, and this is driving further demand for our Lab in Lab model from sleep groups, dentists and first responders.”
This is huge - unsure why it wasn't marked price sensitive ... but who cares
Covid_19 sales slowdown fears drove it down from 70c to the lows of 18c when Cyan was selling out
It now is evident Covid_19 will ACCELERATE their rollout / sales plans as patients are being pushed away from the incumbent CPAP treatment as CPAP spreads Corona!!
Time to sit back & enjoy the re-rate
@Lefevre - What a great way to start the week!!
- Forums
- ASX - By Stock
- OVN
- Ann: COVID-19 environment drives demand for Oventus devices
Ann: COVID-19 environment drives demand for Oventus devices, page-3
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OVN (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online